**Core Concept:**
Muscle relaxants are medications used to paralyze the skeletal muscles during endotracheal intubation to facilitate safe airway management. They work by blocking the neuromuscular transmission at the neuromuscular junction and are classified into rapid-acting and slow-acting types. Rapid-acting muscle relaxants, such as succinylcholine, have a more significant risk of causing hyperkalemia and cardiac arrest due to their rapid action and short duration of action.

**Why the Correct Answer is Right:**
The correct answer is D. Succinylcholine is a rapid-acting muscle relaxant that blocks the neuromuscular junction more effectively than other options. However, succinylcholine has a higher risk of causing hyperkalemia due to the rapid increase in plasma potassium levels. This rapid increase can lead to cardiac arrest, as hyperkalemia impairs myocardial contractility and cardiac conduction, resulting in life-threatening arrhythmias.

**Why Each Wrong Option is Incorrect:**
A. Suxamethonium (Option A) has a similar mechanism to succinylcholine but is less commonly used due to its risk of causing cholinergic crisis, a severe allergic reaction.
B. Rocuronium (Option B) and vecuronium (Option C) are slow-acting muscle relaxants with a lower risk of causing hyperkalemia and cardiac arrest compared to succinylcholine.
D. Sufentanil (Option D) is an opioid analgesic used for anesthesia induction but is not a muscle relaxant and does not contribute to cardiac arrest risk.

**Clinical Pearl:**
In cases where rapid intubation is required, succinylcholine remains a valuable tool due to its speed. However, clinicians should be aware of the potential complications, such as hyperkalemia and cardiac arrest, and consider using alternatives like rocuronium or vecuronium when available. Monitoring of plasma potassium levels and promptly treating hyperkalemia is crucial during succinylcholine administration.